Green Elephant


Felix Wollenhaupt, Dr. Joel Eichmann




Frankfurt School, Justus-Liebig-Universität, Technische Hoschschule Mittelhessen, Philipps-Universität – PwC, UBS, GSK Vaccines

We redefine how the pharmaceutical industry produces adherent cells to cure diseases.

Green Elephant Biotech (GEB) aims to help researchers and the biopharmaceutical industry work more sustainably.  The team pioneered the development and distribution of novel, technologically patented products made of plant-based polymer polylactic acid (PLA).  With these products, GEB redefines how pharmaceutical companies produce adherent cells and address manufacturing challenges to cure diseases.  With a pre-seed funding round of 1.8M, GEB has developed and launched their first product called CellScrew.